3/16/21 19:45 | 3/15/21 | LXRX | Health | Drug | Pharmaceutical Preparations | Tessmer James F | TX | O | VP,Finan | S.d | -158 | 6.92 | 0 | -23 | -24 | 72 | D | | | | | | | | | | | | | | |
6/12/18 16:37 | 6/8/18 | LXRX | Health | Drug | Pharmaceutical Preparations | Tessmer James F | TX | O | VP,Finan | S.d | -129 | 12.91 | 0 | -10 | -28 | 26 | D | | | | | | | | | | | | | | |
6/8/16 08:22 | 6/6/16 | LXRX | Health | Drug | Pharmaceutical Preparations | Tessmer James F | TX | O | VP,Finan | S.d | -23 | 15.00 | 11 | -2 | -9 | 16 | D | 43 | 84 | 9 | 33 | 3 | 18 | 9 | -2 | 1 | -4 | 1 | -2 | 7 | |
5/23/16 17:56 | 5/23/16 | LXRX | Health | Drug | Pharmaceutical Preparations | Tessmer James F | TX | O | VP,Finan | S.d | -78 | 13.00 | 8 | -6 | -27 | 16 | D | 37 | 74 | -9 | 34 | -6 | -13 | 1 | 0 | -3 | 2 | 0 | 17 | 29 | |
5/17/07 17:13 | 5/15/07 | LXRX | Health | Drug | Pharmaceutical Preparations | Piggott James R Phd | TX | O | SVP of P | S | -3 | 3.40 | 0 | -1 | -100 | 0 | D | -22 | -28 | -18 | -16 | -6 | -12 | -6 | -2 | 1 | 4 | -7 | -4 | -4 | -39 |
3/30/07 16:46 | 3/29/07 | LEXG | Health | Drug | Pharmaceutical Preparations | Sands Arthur T | TX | DO | P,CEO | S.d | -684 | 3.60 | 0 | -190 | -11 | 1,560 | D | | | | | | | | | | | | | | |
2/2/07 17:17 | 2/1/07 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Zambrowicz Brian P | TX | O | EVP,Rese | S.d | -203 | 3.89 | 0 | -52 | -34 | 102 | D | | | | | | | | | | | | | | |
4/19/06 16:42 | 4/17/06 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Sands Arthur T | TX | DO | P,CEO | S.m | -77 | 5.11 | 0 | -15 | -1 | 1,450 | B | | | | | | | | | | | | | | |
3/24/06 17:40 | 3/23/06 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Piggott James R Phd | TX | O | SVP of P | S.d | -165 | 5.49 | 0 | -30 | -97 | 1 | | | | | | | | | | | | | | | |
1/5/06 17:30 | 12/30/05 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Gregory Julia P | TX | O | EVP,Corp | S.m | -41 | 3.77 | 0 | -11 | -17 | 55 | B | | | | | | | | | | | | | | |
8/16/05 16:24 | 8/15/05 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Zambrowicz Brian P | TX | O | EVP,Rese | S.d | -144 | 4.63 | 0 | -31 | -33 | 64 | D | | | | | | | | | | | | | | |
8/16/05 16:23 | 8/15/05 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Sands Arthur T | TX | DO | P,CEO | S.d | -1,131 | 4.60 | 0 | -246 | -14 | 1,465 | D | | | | | | | | | | | | | | |
12/29/04 16:36 | 12/28/04 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Gregory Julia P | TX | O | EVP,Corp | S | -23 | 7.60 | 0 | -3 | -4 | 66 | M | | | | | | | | | | | | | | |
12/6/04 16:22 | 12/2/04 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Piggott James R Phd | TX | O | SVP of P | S.d | -141 | 7.07 | 0 | -20 | -95 | 1 | D | | | | | | | | | | | | | | |
5/5/04 17:44 | 5/3/04 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Gregory Julia P | TX | O | EVP,Corp | S.d | -257 | 7.13 | 0 | -36 | -34 | 69 | D | | | | | | | | | | | | | | |
2/25/04 16:13 | 2/23/04 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Randall B | TX | O | SVP,Corp | S.d | -244 | 6.51 | 0 | -38 | -71 | 15 | D | | | | | | | | | | | | | | |
1/13/04 17:01 | 1/9/04 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Person Christophe | TX | O | VP Infor | S.dm | -184 | 6.70 | 0 | -28 | -100 | 0 | D | | | | | | | | | | | | | | |
1/8/04 17:21 | 1/6/04 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Randall B | TX | O | SVP,Corp | S.d | -161 | 6.43 | 0 | -25 | -63 | 15 | D | | | | | | | | | | | | | | |
1/5/04 17:46 | 1/2/04 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Gregory Julia P | TX | O | EVP,Corp | S.d | -48 | 6.02 | 0 | -8 | -10 | 76 | D | | | | | | | | | | | | | | |
12/29/03 14:30 | 12/26/03 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Gregory Julia P | TX | O | EVP,Corp | S | -59 | 5.92 | 0 | -10 | -13 | 65 | D | | | | | | | | | | | | | | |
12/29/03 14:01 | 12/24/03 | LEXG | Health | Diagn | In Vitro & In Vivo Diagnostic | Piggott James R Phd | TX | O | SVP of P | S.dm | -118 | 5.92 | 0 | -20 | -95 | 1 | D | | | | | | | | | | | | | | |